Market for Clinical Decision Support (CDSS) in China is ~US$600 million by 2030Aiyibotong has installed systems in >200 healthcare institutions in ChinaAiyibotong and Treatment.com AI both using proprietary artificial intelligence (AI) and Machine Learning (ML) platformsCo-marketing opportunities in ChinaCombining Aiyibotong’s CDSS with Treatment AI's Global Library of Medicine will look to create further differentiation and increased market share for Aiyibotong in the China and Far East markets VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc.(CSE: TRUE, OTC: TREIF, Frankfurt: 939) ("Treatment”) is pleased to announce it has recently signed a Collaborative Agreement on with Beijing Aiyi Botong Information Technology Ltd Limited ("Aiyibotong”).
As examples, according to Horizon Grand View Research, the clinical decision support (CDSS) market in China alone is expected to double between 2024 and 2030, with a market size of ~US$600 million in 2030 China Clinical Decision Support Systems Market Size & Outlook, 2030 Treatment is partnering with Aiyibotong, a China based healthcare information technology company focused on providing clinical decision supporting solutions (CDSS) for medical professionals in both large hospitals as well as clinics.
The envisaged areas of collaboration include: Aiyibotong assisting Treatment in localization of its Global Library of Medicine (GLM) content and alignment with Chinese medical consensus;Aiyibotong licensing Treatment technology and integration with its’ CDSS platformCo-marketing in China, targeting healthcare institutions and universities;Co-developing an AI based CDSS for the global market, combining Aiyibotong’s value of 10 years of experience in the sector and accumulated data and know-how, together with Treatment’s technology and global medical professionals.
The story "Treatment.com AI and Aiyibotong collaborate to explore commercial opportunities for Clinical Decision Support in China and Far East" has 895 words across 32 sentences, which will take approximately 4 - 8 minutes for the average person to read.
Which news outlet covered this story?
The story "Treatment.com AI and Aiyibotong collaborate to explore commercial opportunities for Clinical Decision Support in China and Far East" was covered 1 days ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 66 news stories per day.
It's most recent story was published 8 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
